RANDOLPH B. SCHIFFER, M.D.
Neurology at 4 St, Lubbock, TX
License number
Texas K8831
Category
Psychiatric
Type
Psychiatry
License number
Texas K8831
Category
Neurology
Type
Neurology
Address
Address
3601 4Th St, Lubbock, TX 79430
Phone
(806) 743-2800
(806) 743-1668 (Fax)
(806) 743-2898
(806) 743-2787 (Fax)
(806) 743-1668 (Fax)
(806) 743-2898
(806) 743-2787 (Fax)
Organization information
See more information about RANDOLPH B. SCHIFFER at bizstanding.comRandolph B Schiffer MD
Ttuhsc 4 & Indiana, Lubbock, TX 79491
Industry:
Medical Doctor's Office
Principal:
Randolph Schiffer (Principal)
Professional information
Dr. Randolph B Schiffer, Las Vegas NV - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology), Neuropsychiatry (Psychiatry)
Address:
888 W Bonneville Ave, Las Vegas 89106
Certifications:
Neurology, 1982, Psychiatry, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
888 W Bonneville Ave, Las Vegas 89106
University Medical Center
602 Indiana Ave, Lubbock 79415
University Medical Center
602 Indiana Ave, Lubbock 79415
Education:
Medical School
University of Mi Med Sch
Graduated: 1976
U Rochester
University Of Michigan Hospitals
University of Mi Med Sch
Graduated: 1976
U Rochester
University Of Michigan Hospitals
Randolph Brenton Schiffer, Lubbock TX
Specialties:
Neurology, Psychiatry
Work:
Texas Tech University
3601 4Th St, Lubbock, TX 79430
3601 4Th St, Lubbock, TX 79430
Education:
University of Michigan Medical School (1976)
Polycyclic Compounds For Use In Treating Ocular Neurodegenerative Diseases
US Patent:
2009014, Jun 4, 2009
Filed:
Dec 4, 2008
Appl. No.:
12/328238
Inventors:
Cornelis J. Van der Schyf - Akron OH, US
Randolph B. Schiffer - Lubbock TX, US
Paula Grammas - Lubbock TX, US
Masao Roy Wilson - Denver CO, US
Werner J. Geldenhuys - Kent OH, US
Randolph B. Schiffer - Lubbock TX, US
Paula Grammas - Lubbock TX, US
Masao Roy Wilson - Denver CO, US
Werner J. Geldenhuys - Kent OH, US
Assignee:
NORTHEASTERN OHIO UNIVERSITIES COLLEGE OF MEDICINE - Rootstown OH
International Classification:
C07D 209/56, A61K 31/403, A61P 27/02
US Classification:
514410, 548420
Abstract:
Described herein are various compounds for treatment of ocular neurodegenerative diseases, including but not limited to glaucoma and diabetic retinopathy. The compounds described herein can act to attenuate and/or block calcium release from external neuronal environments as well as intracellular stores.